Stock Analysis | Revvity Outlook - Bearish Signal Amid Mixed Fundamental Strength

Market Snapshot

Takeaway: Revvity (RVTY) is showing weak technical momentum with bearish signals, but fundamentals show strength. Investors are advised to avoid for now.

News Highlights

Revvity operates in the life sciences sector, which has seen significant activity recently. Notably:

• ConcertAI Launches New AI-Powered Precision Suite (2025-05-30):
• A new AI suite could boost innovation in oncology data, indirectly benefiting life sciences firms like Revvity.
• TriSalus Life Sciences (TLSI) Plans to Offer 5.5M Shares (2025-05-30):
• This move highlights increased financing activity in the sector, which could create both competition and investment opportunities for Revvity.
• TraceLink OPUS Partner Program Grows by 35% (2025-05-27):
• Signs of digital transformation in the life sciences industry may bode well for companies with complementary technologies.

Analyst Views & Fundamentals

Average Rating: 3.50 (simple mean), and 0.00 (weighted rating). Analysts show a poor historical performance, with a 0.00% win rate and negative average returns. This signals a strong divergence from current price trends, which have risen 1.14% recently.

Key Fundamental Values and Model Scores:

• Price-to-Sales (PS) Ratio: 14.71 (value), with an internal diagnostic score of 3.
• Net Cash Flow from Operating Activities / Operating Revenue: 18.95% (value), score: 2.
• Basic Earnings Per Share (YoY Growth Rate): 22.73% (value), score: 2.
• Net Cash Flow from Operating Activities (YoY Growth Rate): -14.28% (value), score: 4.
• Current Assets Turnover Ratio: 0.60% (value), score: 3.
• Cash-UP Factor: -2.67% (value), score: 8 (highest).
• EBIT / Total Operating Revenue: 10.72% (value), score: 3.
• Cash-MV Factor: -0.58% (value), score: 1 (lowest).

The fundamental model score is 8.7, showing strong underlying value. However, technical and analyst signals suggest caution.

Money-Flow Trends

Big money is flowing out of RVTY, with all inflow categories showing a negative trend. The overall inflow ratio is 48.21%, indicating that even medium and large investors are cautious. Retail flows are also weak, with a small inflow ratio of 49.89%.

The fund-flow score is 7.71, which is rated good based on our internal diagnostic model. This suggests that while flows are negative, there's still some structural support.

Key Technical Signals

Technical Score: 3.37, indicating weak technical health and suggesting to avoid the stock.

Recent Technical Indicators and Scores:

• WR Overbought: Biased bearish, internal score 1.
• MACD Golden Cross: Neutral bias, internal score 2.18.
• Dividend Payable Date: Biased bearish, internal score 1.

Recent Indicators by Date:

• 2025-08-15: WR Overbought and MACD Golden Cross triggered
• 2025-08-13: WR Overbought again
• 2025-08-08: WR Oversold and Dividend Payable Date

Overall, bearish signals (3) outnumber bullish ones (0), and the market remains volatile with unclear direction.

Conclusion

While Revvity’s fundamentals are strong—particularly its Cash-UP factor and PS ratio—the technical and analyst signals are bearish. Given the weak technical score of 3.37 and the poor analyst performance, it’s best to avoid entry at this time. Investors may want to wait for a clearer breakout or consider hedging strategies if holding the stock.